Medical Director, Oncology Clinical Development Reports to the Executive Medical Director / Clinical Development Lead. Supports oncology portfolio for treatment of hematological malignancies. Works across early to late-stage development and partners with multidisciplinary oncology drug developers. Requires on-site presence for minimum two days a week at GSK UK (London or Stevenage), US (Greater Philadelphia or Waltham), Canada (Mississauga), Switzerland (Zug), or Poland (Warsaw). Key Responsibilities Collaborate with physicians, scientists, regulatory professionals, biostatisticians, executive staff, and others to develop and execute phase 1-3 interventional clinical trials. Use medical expertise to contribute to end‑to‑end protocol development and timely delivery of clinical trials, ensuring patient safety, scientific integrity and alignment with clinical development strategy. Ensure high‑quality protocol development aligned with early Clinical Development Plan to assess medicine’s efficacy and safety profile. Assume medical responsibility for early‑phase clinical trials, actively monitoring patient eligibility, study design, and urgent safety issues. Review medical data from clinical trials directly or through delegated oversight. Monitor safety data in collaboration with pharmacovigilance group for active studies. Interpret and summarize study results to define safety, efficacy, PK/PD, patient‑reported outcomes, and relevance to target population. Co‑author clinical study reports and regulatory documents, responding to health authority and ethics committee queries with cross‑functional teams. Collaborate with Principal Investigators on publications (abstracts, posters, manuscripts). Network extensively to build long‑term strategic partnerships with thought leaders internally and externally. Serve as core member of the Early Development Team for one or more assets. Participate in Oncology Clinical Development‑wide initiatives and workstreams as appropriate. Basic Qualifications Medical degree with board certification, eligibility, or registration in medical oncology, hematology, or hematology/oncology. Experience in pharmaceutical/biotechnology industry, clinical academic medicine, or clinical practice within hematology or oncology. Oncology clinical drug development experience conducting clinical trials and publishing results. Preferred Qualifications MD or PhD. Clinical experience managing patients with hematological malignancies. Oncology research and drug development experience focused on hematological malignancies, including multiple myeloma. Sound understanding of biological mechanisms, clinical strategy, and evidence‑based literature. Robust knowledge of preclinical and mechanistic translational research, disease‑specific priorities, competitor landscape, and evolving treatment guidelines. Compensation and Benefits US salary ranges for locations in Cambridge, MA; Waltham, MA; Rockville, MD; or San Francisco, CA are $222,750–$371,250. The position includes an annual bonus, eligibility for a share‑based long‑term incentive program, and benefits including health care, retirement, paid holidays, vacation, and caregiver/parental leave. (Country‑specific salary ranges are available upon request.) Equal Opportunity Employer GSK is an Equal Opportunity Employer. All qualified applicants receive equal consideration for employment irrespective of race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), parental status, national origin, age, disability, genetic information, military service, or other bases prohibited under law. #J-18808-Ljbffr